Recombinant Synechococcus sp. Argininosuccinate synthase (argG)

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder. We will preferentially ship the available format. If you have specific format requirements, please note them when ordering.
Lead Time
Delivery times vary by purchase method and location. Consult your local distributor for specifics. All proteins ship with standard blue ice packs. For dry ice shipment, contact us in advance; extra fees apply.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening. Reconstitute in sterile deionized water to 0.1-1.0 mg/mL. Add 5-50% glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50%.
Shelf Life
Shelf life depends on storage conditions, buffer components, temperature, and protein stability. Liquid form: 6 months at -20°C/-80°C. Lyophilized form: 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing. If you require a specific tag, please inform us, and we will prioritize its development.
Synonyms
argG; SynWH7803_2519Argininosuccinate synthase; EC 6.3.4.5; Citrulline--aspartate ligase
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-401
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Synechococcus sp. (strain WH7803)
Target Names
argG
Target Protein Sequence
MGRAKKVVLA YSGGVDTSVC IPYLKQEWGV EEVITFAADL GQGDELEPIR RKALEAGASQ SLVGDLIQPF IEEFAFPAIR ANALYEGRYP LSTALARPLI ARRLVEVARE VGADAVAHGC TGKGNDQVRF DVAIAALAPD LKVLTPAREW GMSREETIAY GERCGLPAPV SKKSPYSIDL NLLGRSVEAG PLEDPMQAPP EEVFAMTVSI DAAPSEAEEI EIAFEAGNPV SINGQRLDPV ALIREANRLA GSHGIGRLDM IENRVVGIKS REIYETPGLL LLIQAHQELE SLTLAADVLR TKRQLEMQWA DLVYQGLWFG PLKEALDGFM DRTQSEVNGV VRLRLHKGNA IVTGRGSSDS SLYVPEMASY GSEDQFDHRA AEGFIYVWGL PIRLWSAARR R
Uniprot No.

Target Background

Database Links
Protein Families
Argininosuccinate synthase family, Type 1 subfamily
Subcellular Location
Cytoplasm.

Q&A

What is argininosuccinate synthase and what role does it play in arginine metabolism in Synechococcus sp.?

Argininosuccinate synthase (encoded by the argG gene) catalyzes the condensation of citrulline and aspartate to form argininosuccinate, which is the immediate precursor of arginine. This reaction represents a critical step in the de novo biosynthetic pathway for arginine . In cyanobacteria like Synechococcus sp., argininosuccinate synthase likely functions in nitrogen assimilation pathways, similar to other enzymes involved in amino acid metabolism. The enzyme plays a central role in providing arginine for various metabolic processes including protein synthesis, nitrogen storage, and potentially specialized metabolic pathways unique to photosynthetic microorganisms.

How does argininosuccinate synthase fit into the broader nitrogen metabolism network in cyanobacteria?

In cyanobacteria, argininosuccinate synthase likely serves as a crucial link between nitrogen assimilation and arginine biosynthesis. While specific data for Synechococcus argG is limited, we can extrapolate from studies of other nitrogen metabolism enzymes in cyanobacteria. For instance, in Synechococcus sp. PCC 7335, a nitric oxide synthase-like protein (syNOS) has been proposed to function in nitrogen utilization from L-arginine . Argininosuccinate synthase would provide the arginine substrate for such pathways, positioning it as an important component in the cyanobacterial nitrogen utilization network. The enzyme likely participates in a metabolic scheme where nitrogen can be efficiently recycled through the citrulline-arginine pathway.

What structural features distinguish cyanobacterial argininosuccinate synthase from homologs in other organisms?

While specific structural data for Synechococcus sp. argG is not yet extensively characterized, argininosuccinate synthase is known to be a ubiquitous enzyme with significant variations in expression, localization, and regulation depending on tissue-specific needs for arginine . Cyanobacterial variants likely possess structural adaptations that optimize function in photosynthetic metabolism. Key structural features may include modifications to substrate binding sites, regulatory domains, and potential interaction surfaces with other proteins involved in nitrogen metabolism. Comparative analysis with the mammalian enzyme indicates the cyanobacterial variant might lack certain regulatory domains associated with hormonal control found in higher organisms.

What expression systems are most effective for recombinant production of Synechococcus sp. argininosuccinate synthase?

Based on successful approaches with other Synechococcus proteins, E. coli expression systems represent a viable starting point for recombinant argG expression. From studies with syNOS from Synechococcus sp. PCC 7335, we know that recombinant expression and purification in E. coli is feasible for cyanobacterial proteins . For optimal expression of argG, researchers should consider:

  • Codon optimization for the host organism

  • Selection of appropriate fusion tags (His6, GST, or MBP) to enhance solubility

  • Testing multiple E. coli strains (BL21(DE3), Rosetta, Arctic Express)

  • Optimizing induction conditions (temperature, IPTG concentration, induction time)

  • Supplementing growth media with potential cofactors

Lower expression temperatures (16-18°C) may enhance proper folding and solubility, as has been demonstrated with other cyanobacterial enzymes.

What purification strategies yield the highest purity and activity for recombinant Synechococcus argG?

A multi-step purification protocol is recommended:

  • Initial capture using affinity chromatography (Ni-NTA for His-tagged constructs)

  • Ion exchange chromatography (typically Q-Sepharose) to remove nucleic acid contaminants

  • Size exclusion chromatography for final polishing and buffer exchange

Table 1: Recommended Buffer Conditions for Purification of Recombinant Synechococcus Proteins

Purification StepBuffer CompositionpHSpecial Considerations
Cell Lysis50 mM Tris-HCl, 300 mM NaCl, 10 mM imidazole, 5% glycerol8.0Include protease inhibitors
Affinity Chromatography50 mM Tris-HCl, 300 mM NaCl, 20-250 mM imidazole gradient8.0Stepwise elution may improve purity
Ion Exchange20 mM Tris-HCl, 50-500 mM NaCl gradient7.5Monitor A260/A280 ratio
Size Exclusion25 mM HEPES, 150 mM NaCl, 10% glycerol7.5Analyze oligomeric state

Maintaining enzyme stability throughout purification is crucial. Addition of 10% glycerol and 1 mM DTT in all buffers can help preserve activity. Based on syNOS studies, argG might be sensitive to oxidation, so reducing agents should be maintained throughout purification .

How can researchers assess the purity and functional integrity of purified recombinant argG?

Multiple complementary techniques should be employed:

  • SDS-PAGE for purity assessment (>95% purity is desirable)

  • Western blotting with anti-His antibodies (if using His-tagged protein)

  • Mass spectrometry for identity confirmation

  • Dynamic light scattering for homogeneity assessment

  • Circular dichroism for secondary structure verification

  • Enzyme activity assays measuring conversion of citrulline and aspartate to argininosuccinate

Activity assays should monitor either the consumption of substrates or formation of products. A coupled assay system linking argininosuccinate production to spectrophotometrically detectable changes (e.g., NADH oxidation) provides convenient real-time monitoring of enzyme activity.

What are the optimal conditions for measuring argininosuccinate synthase activity in recombinant preparations?

Based on general properties of argininosuccinate synthase and specific studies of cyanobacterial enzymes, the following conditions are recommended:

  • Buffer: 50 mM HEPES or Tris-HCl, pH 7.5-8.0

  • Temperature: 25-30°C (physiologically relevant for Synechococcus)

  • Substrate concentrations: 1-5 mM citrulline, 1-5 mM aspartate

  • Cofactor: 2-5 mM ATP, 5-10 mM MgCl₂

  • Ionic strength: 100-150 mM NaCl or KCl

Researchers should systematically optimize these parameters for their specific recombinant preparation. Unlike syNOS, which requires tetrahydrobiopterin , argininosuccinate synthase typically requires only ATP and Mg²⁺ as cofactors.

How do mutations in key catalytic residues affect the activity of Synechococcus argG?

While specific data for Synechococcus argG mutations is not available in the search results, insights can be drawn from site-directed mutagenesis studies of other related enzymes. For instance, in syNOS from Synechococcus, the C539A variant showed very little measurable activity, while the H422A variant exhibited approximately 8-fold reduced activity compared to wild-type .

For argininosuccinate synthase, mutations in the following residues would likely be informative:

  • ATP-binding site residues

  • Citrulline-binding residues

  • Aspartate-binding residues

  • Residues involved in Mg²⁺ coordination

Systematic alanine scanning mutagenesis, combined with kinetic analysis, would provide valuable structure-function information specific to the Synechococcus enzyme.

What kinetic parameters characterize recombinant Synechococcus argG compared to homologs from other organisms?

Table 2: Comparative Kinetic Parameters of Argininosuccinate Synthase from Various Sources

SourceKm Citrulline (mM)Km Aspartate (mM)kcat (s⁻¹)Specific Activity (nmol/min/mg)Reference
Synechococcus sp. (predicted)0.5-2.00.2-1.01-530-60Extrapolated
Mammalian liver0.03-0.150.1-0.33-860-120
E. coli0.2-0.80.1-0.52-640-80Literature

Note: Values for Synechococcus sp. are extrapolated based on typical values for bacterial argininosuccinate synthases and should be experimentally verified. By comparison, syNOS from Synechococcus exhibits a specific activity of 35.7 ± 5 nmol/min/mg .

Cyanobacterial argG likely exhibits temperature and pH optima that reflect the environmental conditions of Synechococcus sp., potentially showing higher activity at elevated temperatures and more alkaline pH compared to mesophilic homologs.

How is argininosuccinate synthase expression regulated in Synechococcus sp.?

In mammalian systems, argininosuccinate synthase expression is regulated by multiple factors including glucocorticoids, cAMP, glucagon, insulin, and substrate availability . While specific regulatory mechanisms in Synechococcus have not been well-characterized, cyanobacterial gene expression is typically responsive to:

  • Nitrogen availability (ammonium, nitrate levels)

  • Light conditions (intensity and wavelength)

  • Carbon availability

  • Cellular energy status

Transcriptional regulation likely involves specific transcription factors that respond to nitrogen status. Post-translational regulation may include feedback inhibition by arginine, similar to mechanisms documented in other organisms .

How does argininosuccinate synthase interact with other enzymes in the arginine biosynthesis pathway in Synechococcus?

Argininosuccinate synthase likely functions in coordination with other enzymes of the urea cycle and arginine biosynthesis pathway. In mammalian systems, argininosuccinate synthase and argininosuccinate lyase are co-localized to facilitate substrate channeling . In Synechococcus, similar spatial organization may exist, potentially with adaptations for the cyanobacterial cellular architecture.

Table 3: Key Enzymes in the Arginine Biosynthesis Pathway in Cyanobacteria

EnzymeFunctionGeneRelationship to argG
Ornithine carbamoyltransferaseConverts ornithine to citrullineargFProvides substrate for argG
Argininosuccinate synthaseConverts citrulline and aspartate to argininosuccinateargG-
Argininosuccinate lyaseCleaves argininosuccinate to arginine and fumarateargHUtilizes argG product
ArginaseConverts arginine to ornithine and urea-May regulate arginine levels
Nitric oxide synthaseConverts arginine to citrulline and NOsyNOSCompetes for arginine substrate

The interplay between these enzymes likely determines the flux through the arginine biosynthesis pathway, with argG potentially serving as a rate-limiting step under certain conditions.

What role does argininosuccinate synthase play in cyanobacterial nitrogen homeostasis?

Argininosuccinate synthase likely plays a crucial role in nitrogen homeostasis in Synechococcus by:

  • Contributing to de novo arginine synthesis for protein production

  • Facilitating nitrogen storage through arginine-rich proteins

  • Enabling nitrogen recycling through the citrulline-NO cycle

The importance of this enzyme in nitrogen metabolism is highlighted by studies of syNOS, which has been proposed to function in nitrogen assimilation from L-Arg . In this context, argG would provide the necessary arginine substrate for such nitrogen utilization pathways. During nitrogen limitation, upregulation of argG might occur to maximize efficient nitrogen utilization and recycling.

How can recombinant Synechococcus argG be used to study the evolution of arginine metabolism across cyanobacterial lineages?

Recombinant argG provides a valuable tool for evolutionary studies through:

  • Comparative biochemical characterization of argG from diverse cyanobacterial lineages

  • Reconstruction of ancestral argG sequences and expression of these reconstructed enzymes

  • Complementation studies in argG-deficient mutants across species

  • Analysis of selective pressures on argG sequences in different ecological niches

Such studies could reveal how arginine metabolism has adapted to diverse environmental conditions throughout cyanobacterial evolution, potentially uncovering specialized functions in certain lineages. The relationship between argG and other nitrogen metabolism enzymes, such as syNOS, could provide insights into the co-evolution of these metabolic pathways .

What biotechnological applications might benefit from recombinant Synechococcus argG?

Several potential applications exist:

  • Biocatalysis for arginine and derivatives production

  • Engineering nitrogen-efficient photosynthetic organisms

  • Development of biosensors for citrulline/aspartate detection

  • Production of isotopically labeled arginine for metabolic studies

  • Enzyme immobilization for continuous production systems

The thermostability and potential salt tolerance of Synechococcus argG might make it particularly suitable for certain industrial applications requiring robust catalysts. Additionally, understanding the regulation and activity of argG could inform metabolic engineering strategies for enhanced nitrogen fixation and utilization in cyanobacteria.

How do post-translational modifications affect the activity and stability of Synechococcus argG?

While specific data on post-translational modifications (PTMs) of Synechococcus argG is not available in the search results, several possibilities should be investigated:

  • Phosphorylation: Likely affects enzyme activity in response to energy/nitrogen status

  • Acetylation: May regulate activity based on carbon availability

  • Oxidative modifications: Could impact enzyme stability under stress conditions

  • S-nitrosylation: Potentially provides feedback regulation related to NO production

Recombinant expression systems may not reproduce native PTMs, potentially explaining differences between recombinant and native enzyme activities. Mass spectrometry-based proteomics approaches would be valuable for mapping the PTM landscape of native argG. Researchers should consider how the absence of these modifications in recombinant preparations might affect kinetic parameters and regulatory properties.

What strategies can overcome common challenges in the heterologous expression of Synechococcus argG?

Researchers often encounter several challenges when expressing cyanobacterial proteins:

  • Codon bias: Use codon-optimized synthetic genes or expression in Rosetta strains

  • Protein solubility: Employ solubility-enhancing fusion tags (MBP, SUMO) or express at lower temperatures (16-18°C)

  • Protein stability: Include stabilizing additives (glycerol, reducing agents) in purification buffers

  • Proper folding: Co-express with molecular chaperones (GroEL/ES, DnaK systems)

  • Cofactor incorporation: Supplement growth media with required cofactors

Drawing from experience with syNOS expression , researchers should be particularly attentive to buffer conditions during purification, as cyanobacterial proteins may have specific requirements for ionic strength and pH that differ from model proteins.

How can researchers develop effective activity assays for recombinant Synechococcus argG?

Multiple complementary assay approaches should be considered:

  • Direct product detection: HPLC or LC-MS/MS quantification of argininosuccinate formation

  • Coupled enzyme assays: Link argininosuccinate formation to spectrophotometric changes

  • ADP formation assays: Measure ATP consumption using commercially available kits

  • Radiometric assays: Using 14C-labeled substrates for highest sensitivity

Table 4: Comparison of Assay Methods for Argininosuccinate Synthase Activity

Assay MethodSensitivityThroughputEquipment RequirementsAdvantagesLimitations
HPLC/LC-MSHighLowSpecializedDirect product measurementTime-consuming, expensive
Coupled enzymeMediumHighStandard plate readerReal-time monitoringPotential interference
ADP formationMedium-HighHighLuminometerFast, commercial kits availableIndirect measurement
RadiometricVery highLowScintillation counterHighest sensitivityRequires radioactive handling

When developing these assays, researchers should include appropriate controls, such as heat-inactivated enzyme and no-substrate controls, to ensure specificity of the measured activity.

What are the best approaches for structural studies of Synechococcus argG?

Several complementary approaches can provide structural insights:

Each approach has specific sample requirements and provides different types of structural information. A combination of these methods would provide the most comprehensive structural characterization of Synechococcus argG. For instance, crystallography could reveal atomic details of the active site, while SAXS might elucidate the quaternary structure and potential oligomerization states.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.